Akeso, Inc. Appoints New CFO, Dr. Bing Wang
Company Announcements

Akeso, Inc. Appoints New CFO, Dr. Bing Wang

Akeso, Inc. (HK:9926) has released an update.

Akeso, Inc., a biopharmaceutical firm, announced the appointment of Bing C. Wang, Ph.D., as its new Chief Financial Officer, effective July 22, 2024. Dr. Wang, an experienced biotech executive, joins the company with a rich background, including previous roles as CFO of Cellectis S.A. and CEO of Refuge Biotechnologies, Inc. The company’s board expressed enthusiasm for Dr. Wang’s arrival and the expertise he brings to Akeso’s financial strategies.

For further insights into HK:9926 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App